Evidence map›Paper›PMID 28784701›Full record

Trial reportPediatrics2017

Early Probiotic Supplementation for Eczema and Asthma Prevention: A Randomized Controlled Trial.

Michael D Cabana, Michelle McKean, Aaron B Caughey, Lawrence Fong, Susan Lynch, Angela Wong, Russell Leong, Homer A Boushey, Joan F Hilton

Registry-linked trialOpen access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Pediatrics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04662619 (A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled, Two-Arm, Parallel-Group, Nutritional Intervention Study to Examine the Clinical and Immunological Effects of a Probiotic Food Supplement Containing B. Infantis), which is not on this map. Cited by 85 papers, 11 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed, 11 pooled it
25.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04662619 nacompletednot on this mapstarted 2020, after this paper: background citation

A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled, Two-Arm, Parallel-Group, Nutritional Intervention Study to Examine the Clinical and Immunological Effects of a Probiotic Food Supplement Containing B. Infantis (EVC001) in Healthy Breastfed Infants at Risk of Developing Atopic Dermatitis

TypeinterventionalSponsorJohnson & Johnson Consumer Inc. (J&JCI)Ran2020 to 2024Enrolled273ConditionsHealthyArmsB. infantis, Lactose Placebo
3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 11 syntheses or guidelines pooled it, 143 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Probiotics in infants for prevention of allergic disease.The Cochrane database of systematic reviews · 2025
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Can Mixed Strains ofNutrients · 2021
    Pooled it
  7. Pooled it
  8. Frontiers in pediatrics · 2021
    Pooled it
  9. Pooled it
  10. Pooled it
  11. Nutrients · 2018
    Pooled it
  12. Trial
  13. Trial
  14. Pilot Analysis of Early Lactobacillus rhamnosus GG for Infant Colic Prevention.Journal of pediatric gastroenterology and nutrition · 2019
    Trial
  15. Trial
  16. Review
  17. Review
  18. [Gut microbiota and allergic diseases].Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2026
    Review
  19. Review
  20. Review

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Michael D CabanaDepartments of Pediatrics, michael.cabana@ucsf.edu.
Michelle McKeanDepartments of Pediatrics.
Aaron B CaugheyDepartment of Obstetrics and Gynecology, Oregon Health & Sciences University, Portland, Oregon.
Lawrence FongMedicine, and.
Susan LynchMedicine, and.
Angela WongDepartment of Pediatrics, Kaiser Permanente, San Francisco, California; and.
Russell LeongDepartment of Pediatrics, California Pacific Medical Center, San Francisco, California.
Homer A BousheyMedicine, and.
Joan F HiltonEpidemiology and Biostatistics.
California Pacific Medical Center · USCancer Research And Biostatistics · USKaiser Permanente San Francisco Medical Center · USOregon Health & Science University · USPediatrics and Genetics · USUniversity of California, San Francisco · US

Funding

UCSF CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTEUL1RR024131 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JOHNSTON, S. CLAIBORNE · 2006 to 2011
$111.2M
Trial of Infant Probiotic Exposure on Developing AsthmaR01HL080074 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CABANA, MICHAEL D · 2004 to 2008
$2.4M
NCRR NIH HHS UL1 RR024131NHLBI NIH HHS R01 HL080074
6 · The paper itself

Abstract

objectivesTo determine if probiotic administration during the first 6 months of life decreases childhood asthma and eczema.

methodsWe conducted a randomized, double-blind controlled trial of

resultsInfants were accrued over a 6-year period (median follow-up: 4.6 years; 95% retention rate at 2 years). At 2 years of age, the estimated cumulative incidence of eczema was 30.9% (95% confidence interval [CI], 21.4%-40.4%) in the control arm and 28.7% (95% CI, 19.4%-38.0%) in the LGG arm, for a hazard ratio of 0.95 (95% CI, 0.59-1.53) (log-rank

conclusionsFor high-risk infants, early LGG supplementation for the first 6 months of life does not appear to prevent the development of eczema or asthma at 2 years of age.

Indexed as

AsthmaChild, PreschoolDietary SupplementsDouble-Blind MethodEczemaFemaleFollow-Up StudiesHumansIncidenceInfantLacticaseibacillus rhamnosusMaleProbioticsSurvival Analysis

Identifiers

PMID28784701
PMCPMC5574725
OpenAlexW2744729065

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.